Vivani (NASDAQ: VANI) insider Gregg Williams lifts indirect stake 0.3%

What happened

Gregg Williams, a director of Vivani Medical, Inc. (NASDAQ: VANI), bought 118,434 shares of common stock. The open-market purchases added to a stake held mostly through other entities without bringing new cash into Vivani.

Williams, listed as a 10% owner, spent about $128,000 over two trading days. Most of the buying came on the second day, when Williams also paid more per share on average.

On Nov. 18, Williams bought 33,169 shares at a weighted average of $1.05. Individual trades that day ranged from $1.02 to $1.07 per share.

On Nov. 19, Williams bought 85,265 shares at a weighted average of $1.10. Individual trades that day ranged from $1.06 to $1.13 per share, rounded to the nearest cent.

Key numbers

Metric Latest Change Source
Common shares purchased 118,434 shares SEC Form 4
Total purchase value About $128,325 Calculated from SEC Form 4
Individual trade price range, rounded to the nearest cent $1.02 to $1.13 per share SEC Form 4
Indirect holdings after the purchases 37,111,299 shares SEC Form 4
Direct holdings 4,799,200 shares SEC Form 4
Combined direct and indirect holdings after the purchases 41,910,499 shares SEC Form 4

Read more: Vivani Medical (VANI) company research

Why it matters

The purchases were a small addition even when measured against only the indirect stake. They increased Williams's indirect holdings by 0.3% from the 36,992,865 shares held before the first purchase, OptimistFi calculates.

The purchases brought the indirect position to 37,111,299 shares, separate from the 4,799,200 shares Williams owned directly. Williams had voting and selling authority over both parts of the stake, which totaled 41,910,499 shares after the purchases.

The Gregg G. Williams 2006 Trust accounted for most of the indirect position, with 34,985,547 shares. Williams International Co. LLC held the next-largest indirect block, with 1,212,856 shares.

The rest of the indirect stake was split between the Sam B. Williams 1995 Generation-Skipping Trust, with 731,309 shares, and Sam Williams Family Investments LLC, with 181,587 shares.

OptimistFi has argued that Vivani's implants need to make chronic-drug delivery easier and more consistent before cash burn and dilution erode the upside. The purchases increase Williams's exposure to that outcome but leave the investment case unchanged.

Stock perps: every US stock that trades as a perpetual future, by leverage, live

What's next

At Vivani's next quarterly report, lower operating cash use than in the prior quarter would ease the funding pressure OptimistFi sees on implant development.

More from OptimistFi

From OptimistFi Perps

Sources

  • SEC Form 4 — Signed Nov. 20, 2026. Table I and its footnotes give the two purchases, their price ranges and the breakdown of direct and indirect holdings.

Explore OptimistFi research on Vivani Medical, Inc.: https://optimistfi.com/stocks/VANI

Browse Vivani Medical, Inc. company coverage and explore the OptimistFi Thesis-Break Engine.

Browse every company OptimistFi covers at optimistfi.com/stocks, or read the latest evidence-first research.

Find available research on the Vivani Medical, Inc. company page.

Originally published on OptimistFi, evidence-first equity research. More at optimistfi.com.